Brief: Attovia Therapeutics Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
02/09/2026 21:46
BRIEF-Attovia Therapeutics Reports Second Quarter 2026 Financial Results And Provides A Corporate Update Sept 2 (Reuters) - Attovia Therapeutics Inc ATTO.O:
ATTOVIA THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
ATTOVIA THERAPEUTICS - Q2 COLLABORATION REVENUE WAS $0.50 MILLION
ATTOVIA THERAPEUTICS - Q2 NET LOSS WAS $20.70 MILLION
Source text: ID:nGNXcPxZz
Further company coverage: ATTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Attovia Therapeutics
See all newsBrief: Attovia Therapeutics Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
Attovia Therapeutics jumps in Nasdaq debut after upsized $289 million IPO
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
NASDAQ RESUMED AT 12:18 PM